Loading DWARKESH price...
Peers are the listed companies in the exchange's own industry group: Sugar. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 28 Jul 2026), sales fell 11.7% from a year earlier to Rs 358 cr and the loss was Rs 25.7 cr against Rs 9.4 cr a year earlier.
- Operating margin fell from 10.4% in FY23 to 6.2% in FY26.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 20 results, the share rose on 2 and fell on 18, and moved by 3% or more on 10.
Q1 FY27: results filed 28 Jul 2026. The share went from its close on 27 Jul 2026 to its close on 29 Jul 2026 -10.63%.
Of every Rs 100 of sales in FY26, Rs 94 went on running costs, Rs 2.6 on depreciation, Rs 1.1 on interest and Rs 0.8 on tax; Rs 2.2 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | 6.5% | -18.7% | -20.5% | 3.2% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | 14.7% | 10.4% | 12.0% | 8.3% | 6.2% |
| Net marginProfit after everything, per Rs 100 of sales. | 7.9% | 5.0% | 4.9% | 1.7% | 2.2% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | 14.2% | 10.2% | 2.9% | 3.7% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | - | 18.2% | 15.9% | 7.2% | 5.9% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | - | 0.50x | 0.55x | 0.62x | 0.40x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | 7.9x | 6.2x | 8.2x | 3.8x | 3.9x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 1,298 Cr of assets. Its owners funded 64% of that and borrowings 26%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs 129 Cr, spent Rs 7 Cr on plant and equipment, and cash fell by Rs 69 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| BAJAJHIND Bajaj Hindusthan Sugar Limited | 54,402 cr | 14.3x | 14.3x | 3.0% | 1.9% | 0.93 | 2.2% | -9.8% | 0.00% |
| BALRAMCHIN Balrampur Chini Mills Limited | 13,212 cr | 34.3x | 3.2x | 9.0% | 11.1% | 0.77 | 5.8% | +6.1% | 0.54% |
| TRIVENI Triveni Engineering & Industries Limited | 4,979 cr | 17.7x | 1.5x | 8.1% | 11.9% | 0.64 | 3.5% | -0.2% | 1.76% |
| BANARISUG Bannari Amman Sugars Limited | 4,029 cr | 33.1x | 2.1x | 6.4% | 8.8% | 0.00 | 7.3% | -58.8% | 0.39% |
| RENUKA Shree Renuka Sugars Limited | 3,858 cr | - | - | 29.1% | -16.9% | - | -8.3% | +5.5% | 0.00% |
| DALMIASUG Dalmia Bharat Sugar and Industries Limited | 3,357 cr | 16.5x | 1.0x | 6.3% | 9.6% | 0.55 | 5.8% | -10.0% | 1.45% |
| AVADHSUGAR Avadh Sugar & Energy Limited | 1,627 cr | 24.7x | 1.4x | 5.9% | 10.3% | 1.25 | 2.4% | +8.7% | 1.23% |
| UTTAMSUGAR Uttam Sugar Mills Limited | 1,179 cr | 13.6x | 1.4x | 9.8% | 17.6% | 0.81 | 4.0% | -3.6% | 0.87% |
| DHAMPURSUG Dhampur Sugar Mills Limited | 1,095 cr | 15.6x | 0.9x | 5.9% | 9.2% | 0.73 | 2.5% | +6.1% | 0.02% |
| DBOL Dhampur Bio Organics Limited | 806 cr | 9.6x | 0.8x | 8.2% | 7.9% | 1.03 | 2.6% | +17.2% | 1.03% |
| DWARKESH Dwarikesh Sugar Industries Limited | 774 cr | 53.6x | 0.9x | 1.8% | 5.9% | 0.40 | 1.1% | -11.7% | 1.20% |
| MAGADSUGAR Magadh Sugar & Energy Limited | 711 cr | 13.9x | 0.8x | 5.8% | 10.7% | 0.79 | 4.2% | -6.8% | 2.48% |
| ZUARIIND ZUARI INDUSTRIES LIMITED | 692 cr | 6.4x | 0.2x | 3.0% | 2.8% | 0.72 | 9.7% | +21.2% | 0.63% |
| MAWANASUG Mawana Sugars Limited | 599 cr | 21.7x | 1.1x | 5.2% | 13.4% | 0.80 | 1.7% | +3.8% | 0.65% |
| DCMSRIND DCM Shriram Industries Limited | 448 cr | 17.3x | 1.2x | 7.1% | 17.7% | 1.16 | 1.9% | -41.1% | 3.84% |
| PONNIERODE Ponni Sugars (Erode) Limited | 282 cr | 5.7x | 0.5x | 8.7% | 14.8% | 0.00 | 11.1% | +52.2% | 0.92% |
| KMSUGAR K.M.Sugar Mills Limited | 263 cr | 3.8x | 0.7x | 12.3% | 20.6% | 0.64 | 7.5% | -8.8% | 0.00% |
| KCPSUGIND KCP Sugar and Industries Corporation Limited | 259 cr | 6.8x | 0.6x | 8.3% | 4.4% | 0.28 | 13.7% | +31.4% | 0.44% |
| SAKHTISUG Sakthi Sugars Limited | 200 cr | 7.3x | 0.9x | 12.0% | 15.5% | 3.15 | 2.8% | +24.6% | 0.00% |
| KOTARISUG Kothari Sugars And Chemicals Limited | 193 cr | 35.3x | 0.7x | 1.8% | 0.6% | 0.24 | 2.1% | +25.1% | 0.00% |
| VISHWARAJ Vishwaraj Sugar Industries Limited | 104 cr | - | 0.4x | -14.2% | -5.4% | 1.66 | -10.3% | -19.5% | 0.00% |
| RAJSREESUG Rajshree Sugars & Chemicals Limited | 87 cr | - | 0.3x | -3.1% | 3.2% | 1.26 | -1.4% | +8.7% | 0.00% |
| PRUDMOULI Prudential Sugar Corporation Limited | 46 cr | 4.5x | 0.4x | 6.5% | 7.7% | 0.39 | 7.1% | +222.2% | 0.00% |
| SIMBHALS Simbhaoli Sugars Limited | 28 cr | - | - | 43.7% | 36.5% | - | -9.1% | -37.1% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 14.7% to 6.2% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
2023 paid Rs 2.00 per share, about Rs 4,787 on Rs 1 lakh at today's price. It skipped 3 of the last 7 years. Dividends are at the company's discretion and can be cut or skipped.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-08-31 | HRTI PRIVATE LIMITED | SELL | 11,51,414 | 52.51 | Rs 6.05 Cr |
| 2026-08-31 | HRTI PRIVATE LIMITED | BUY | 11,11,219 | 52.47 | Rs 5.83 Cr |
| 2026-08-26 | HRTI PRIVATE LIMITED | SELL | 9,80,178 | 53.88 | Rs 5.28 Cr |
| 2026-08-26 | HRTI PRIVATE LIMITED | BUY | 9,10,889 | 53.71 | Rs 4.89 Cr |
| 2026-08-24 | JUNOMONETA FINSOL PRIVATE LIMITED | BUY | 16,38,479 | 57.37 | Rs 9.4 Cr |
| 2026-08-24 | JUNOMONETA FINSOL PRIVATE LIMITED | SELL | 16,38,455 | 57.37 | Rs 9.4 Cr |
| 2026-08-24 | HRTI PRIVATE LIMITED | BUY | 15,12,252 | 57.37 | Rs 8.68 Cr |
| 2026-08-24 | HRTI PRIVATE LIMITED | SELL | 14,54,086 | 57.49 | Rs 8.36 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.